February 25 - 26, 2013    Las Vegas NV , USA
GTC’s 3rd Ubiquitin Research and Drug Discovery conference, one of three parallel tracks of the 2nd Novel Cancer Therapeutic Summit on February 25 - 26, 2013 in Las Vegas, NV, brings together a balanced mix of experts from industry, academia, biotech and government to collaborate on cutting edge research on the Ubiquitin Pathway, SUMO, Ligases and much more. This year's keynote speaker Aaron Ciechanover won the Nobel Prize for his work in Ubiquitin and two featured speakers Ray Deshaies and Rachel Klevit are recognized leaders in the field of Ubiquitin. With a number of conferences held in cities across the country this conference will be as unique as the city it is held in. Leaders in the field of Ubiquitin, panel discussions and information sharing as well as world class gaming, entertainment and restaurants this conference promises not to disappoint.

• Keynote Speaker
Aaron Ciechanover

tentative sessions for the 3rd Ubiquitin Research and Drug Discovery Conference

Proteasome Structure and Function
Structure/function studies of E3 Ligase Catalysis
Ubiquitin in Autophagy
Deubiquitinating Enzymes as Drug Targets
Novel drug targets in the Ubiquitin System
Ubiquitin-like Modifications – New Opportunities

Venue

Location: Palms Casino Resort
Contact 4321 W Flamingo Rd. Las Vegas , USA

Organizer

Global Technology Community
434 W. Foothill Blvd | Monrovia, CA 91016
626-256-6405